CDISC SDTM and ADaM for survival data - ppt download
Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review | British Journal of Cancer
Progression‑free survival of first‑line treatment with molecular‑targeted therapy may be a meaningful intermediate endpoint for overall survival in patients with metastatic renal cell carcinoma
Clinical Trial Design - Endpoints - Quantics Biostatistics
Evolving Oncology Endpoints - IQVIA
Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival - Journal of Hepatology
Endpoints Used in Clinical Trials Endpoint Definition Overall survival... | Download Table
Surrogate Endpoint | Definitive Healthcare
Figure: QUAZAR AML-001 primary endpoint: overall survival from... | Download Scientific Diagram
Disease-Free Survival As a Clinical Trial Endpoint: Does It Matter, and to Whom?
Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis - The Lancet Oncology
Merck Announces KEYTRUDA® (pembrolizumab) Met Primary Endpoint of Overall Survival (OS) in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Sorafenib | Business Wire
Recommendations to meet statistical challenges arising from endpoints beyond overall survival in clinical trials on chronic myeloid leukemia | Leukemia
Surrogate endpoints for overall survival in digestive oncology trials: which candidates? A questionnaires survey among clinicians and methodologists | BMC Cancer | Full Text
Kaplan-Meier estimates of (a) the primary endpoint of progression free... | Download Scientific Diagram
Cumulative overall survival (OS) and progression-free survival (PFS)... | Download Scientific Diagram
JAMA Oncology on Twitter: "Radiographic progression-free survival in PREVAIL trial of #enzalutamide vs placebo for met castration-resistant #ProstateCancer is reliable & clinically meaningful endpoint highly assoc'd w overall survival https://t.co ...
Progression-free survival as a surrogate endpoint in advanced neuroendocrine neoplasms in: Endocrine-Related Cancer Volume 24 Issue 9 (2017)
Progression-free survival is a robust surrogate endpoint of overall survival in immunotherapy trials of hepatocellular carcinoma - Digestive and Liver Disease
Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer† - Annals of Oncology
Do Surrogate Endpoints Better Correlate with Overall Survival in Studies That Did Not Allow for Crossover or Reported Balanced Postprogression Treatments? An Application in Advanced Non–Small Cell Lung Cancer - Value in
Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer: ARTemis Trial - Annals of
Intermediate clinical endpoints: A bridge between progression‐free survival and overall survival in ovarian cancer trials - Matulonis - 2015 - Cancer - Wiley Online Library
図10 Overall survival (primary endpoint)
Survival in oncology reimbursement decision-making | CMAR
